Prosecution Insights
Last updated: May 29, 2026

Examiner: COLENA, TRACY CHING-TIAN

Tech Center 1700 • Art Units: 1797 1798

This examiner grants 100% of resolved cases

Performance Statistics

100.0%
Allow Rate
+35.0% vs TC avg
31
Total Applications
+0.0%
Interview Lift
1066
Avg Prosecution Days
Based on 4 resolved cases, 2023–2026

Rejection Statute Breakdown

0%
§101 Eligibility
0%
§102 Novelty
89.2%
§103 Obviousness
5.4%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18036031 POLYOL BIOMARKERS FOR CONGENITAL DISORDERS OF GLYCOSYLATION Non-Final OA Mayo Foundation for Medical Education and Research
18254489 MONOCLONAL ANTIBODY-BASED BIOSENSOR FOR POINT-OF-CARE DETECTION OF TYPE III SECRETION SYSTEM EXPRESSING PATHOGENS Non-Final OA THE STATE OF ISRAEL, MINISTRY OF AGRICULTURE & RURAL DEVELOPMENT, AGRICULTURAL RESEARCH ORGANIZATION
18069198 DETERMINATION OF OXIDIZING SUBSTANCES USING PEPTIDE DEGRADATION Non-Final OA Baxter Healthcare SA
18135539 POLYMER FILM RESISTANCE FUEL DETECTOR Non-Final OA King Abdullah University of Science and Technology
18248818 METHODS FOR TREATING AND MONITORING FRONTOTEMPORAL DEMENTIA Non-Final OA Denali Therapeutics Inc.
18264795 A SYSTEM AND METHOD FOR DETERMINING A CONCENTRATION OF AN ANALYTE IN A FLUID Non-Final OA AUSMED GLOBAL LIMITED
18269896 SYSTEMS AND METHODS FOR ANALYTE ANALYSIS Non-Final OA COMBINATI INCORPORTATED
18269154 SELECTIVE MONITORING OF BASE CHEMICALS Final Rejection ECI TECHNOLOGY, INC.
18267057 SAMPLE POOLING DEVICE AND SAMPLE POOLING SYSTEM Non-Final OA UNIVERSAL BIO RESEARCH CO., LTD.
18266527 DIAGNOSIS OF AUTISM SPECTRUM DISORDER Non-Final OA STALICLA SA
18309215 DIGITAL MOLECULAR ASSAYS Non-Final OA ILYTICA LLC
18140902 Methods, Systems & Kits for Prediction, Detection, Monitoring & Treatment of Alzheimer's Disease Non-Final OA Baseline Bioscience, Inc.
18303069 KYNURENINE: USEFUL BIOMARKER IN ACUTE COVID-19 AND LONG COVID Non-Final OA Salion GmbH

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month